Thomas Clarke (University of Technology, Sydney, Australia)

International Corporate Governance

• Broschiertes Buch

Produktbeschreibung

Thomas Clarkeâ s International Corporate Governance offers a panoramic guide to corporate governance and examines the recurring crises in governance and the reform around the world.

---

Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.

Produktdetails

• Verlag: Taylor & Francis Ltd
• 3 ed
• Seitenzahl: 818
• Erscheinungstermin: 29. August 2023
• Englisch
• Abmessung: 248mm x 180mm x 57mm
• Gewicht: 1422g
• ISBN-13: 9781032019376
• ISBN-10: 1032019379
• Artikelnr.: 66872078

Autorenporträt

Thomas Clarke is a Fellow of the Royal Society of Arts, and formerly Professor of Management at the China Europe International Business School (CEIBS), and at UTS Sydney. Visiting Professor at the University of Paris, University of Geneva, Toulouse Business School, FGV in Brazil, and UNAM in Mexico. He was a member of the RSA Tomorrow's Company Inquiry that influenced the review of UK Company Law, and at the OECD in Paris helped develop the corporate governance code adopted by governments throughout the world. In 2016 he was awarded the inaugural Sir Adrian Cadbury Scholarship by the International Corporate Governance Network (ICGN).

Inhaltsangabe

Table of Contents:
Forword
Preface
1. Cycles of Governance
2. Boards and Directors: The Political Mechanisms of Corporate
Governance
3. Finance, Law, and Markets: The Institutional Elements of Corporate
Governance
4. Anglo-American Corporate Governance
5. European Corporate Governance
6. Asia Pacific Corporate Governance
7. The Globalization of Corporate Governance
8. Corporate Social Responsibility
9. Corporate Governance and Climate Change
10. Corporate Sustainability
Case Studies: Corporate Governance Crisis
Global Financial Crisis Cases (2007-2009)
1. Lehman Brothers
2. RBS
3. UBS
4. Iceland
Asia-Pacific Cases (2009-2022)
5. Satyam
6. Olympus
7. Renault-Nissan
Sustainability Cases (2010-2022)
8. BP
9. VW
10. Boeing
11. GM/Tesla
12. Apple
Public Health Cases (2003-2022)
13. Purdue Pharma
14. Theranos